fingolimod hydrochloride has been researched along with Herpes Simplex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Löbermann, M; Reisinger, EC; Winkelmann, A; Zettl, UK | 1 |
| Bedoui, S; Carbone, FR; Eidsmo, L; Heath, WR; Stock, AT | 1 |
2 other study(ies) available for fingolimod hydrochloride and Herpes Simplex
| Article | Year |
|---|---|
[Fingolimod treatment for multiple sclerosis patients. Infectiological aspects and recommendations for vaccinations].
Topics: Fingolimod Hydrochloride; Herpes Simplex; Humans; Immunization, Secondary; Immunosuppressive Agents; Multiple Sclerosis; Propylene Glycols; Sphingosine | 2012 |
Reactive murine lymph nodes uniquely permit parenchymal access for T cells that enter via the afferent lymphatics.
Topics: Adoptive Transfer; Animals; Chemotaxis, Leukocyte; Disease Models, Animal; Fingolimod Hydrochloride; Genes, T-Cell Receptor; Herpes Simplex; Herpesvirus 1, Human; Immunosuppressive Agents; Lymph Nodes; Lymphatic Vessels; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Transgenic; Propylene Glycols; Skin; Sphingosine; T-Lymphocytes; Time Factors | 2012 |